Company
MUSTANG BIO, INC. (MBIO)
Standardized SEC financial data for MUSTANG BIO, INC. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001680048 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-20.2%
Free cash flow
-$5.3M
Current ratio
2.22×
EPS (diluted)
$-0.39
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $37.2M | $49.9M | $62.5M | $40.5M | $7.6M | — |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $98.8M | $110.6M | $76.7M | $7.0M | $6.8M | $17.3M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$37.3M | -$53.7M | -$65.1M | -$49.5M | -$11.4M | -$5.3M |
| Capital expenditures |
Get MBIO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MBIO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MBIO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"